Skip to content
Clinical Trials – home
VerifiedinfoResponsive

Cliniques Universitaires Saint-Luc

Belgium Hippokrateslaan 10, Batiment 54, 1200 Woluwe-Saint-Lambert, Belgium

  • 271 trials recruiting
  • Crohn's disease · Ovarian cancer · Colorectal cancer metastatic
  • Adults and children

About Specializations

Cliniques Universitaires Saint-Luc in Woluwe-Saint-Lambert, Belgium specialises in clinical trials of conditions such as Crohn's disease, Ovarian cancer, Colorectal cancer metastatic, Breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology

The medical center is at the forefront of research in gastroenterology, focusing on innovative treatments for inflammatory bowel diseases. The center's work in this field is pivotal in advancing therapeutic options for conditions such as ulcerative colitis and Crohn's disease.

  • Ulcerative Colitis
  • Crohn's Disease
  • Inflammatory Bowel Diseases

Through rigorous clinical trials, the center is exploring the efficacy of novel biologics and targeted therapies, aiming to improve patient outcomes and quality of life.

Oncology

Specializing in oncology, the center is dedicated to developing cutting-edge treatments for various cancers, including solid tumors and hematologic malignancies. The research conducted here is instrumental in enhancing the understanding of cancer biology and treatment.

  • Solid Tumors
  • Breast Cancer
  • Non-small Cell Lung Cancer

The center's commitment to personalized medicine is evident in its efforts to tailor therapies based on genetic and molecular profiles, thereby optimizing treatment efficacy and minimizing adverse effects.

Neurology

In the realm of neurology, the center is pioneering research into neurodegenerative diseases and neurological disorders. Its work is crucial in developing therapies that target the underlying mechanisms of conditions such as Alzheimer's disease and epilepsy.

  • Alzheimer's Disease
  • Epilepsy
  • Chronic Inflammatory Demyelinating Polyneuropathy

By leveraging advanced imaging techniques and biomarker analysis, the center aims to enhance early diagnosis and intervention strategies, ultimately improving patient care and outcomes.

Immunology

The center's research in immunology is focused on understanding and manipulating the immune system to treat autoimmune diseases and enhance vaccine efficacy. This research is vital for developing new therapeutic approaches for conditions like psoriatic arthritis and hemophilia.

  • Psoriatic Arthritis
  • Hemophilia
  • Chronic Plaque Psoriasis

Through innovative clinical trials, the center is exploring the potential of gene therapy and biologics to modulate immune responses and achieve long-term disease remission.

Nephrology

In nephrology, the center is advancing research on kidney diseases, particularly focusing on genetic and proteinuric conditions. The center's efforts are crucial in developing targeted therapies for diseases such as APOL1-mediated kidney disease.

  • APOL1-mediated Kidney Disease
  • Chronic Kidney Disease

By integrating genetic research with clinical applications, the center aims to provide personalized treatment options that address the specific needs of patients with complex renal conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hippokrateslaan 10, Batiment 541200 Woluwe-Saint-LambertBelgium
Recruiting now
271 trials
Conditions studied
212
Partner status
Verified

More sites in Woluwe-Saint-LambertBelgium

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

663 clinical trials

Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE

Psoriasis

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Exelixis Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Darovasertib
  • Sponsor:Ideaya Biosciences Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).